Table 2.

Overview of the above described miRNAs involved in canine and human cancer.

MAMMARY TUMORS
cfa-let-7f	↑	hsa-let-7f-5p	↑
cfa-miR-15a	↓	hsa-miR-15a-5p	↓
cfa-miR-16	↓	hsa-miR-16-5p	↓
cfa-miR-17-5p	↓	hsa-miR-17-5p	↓
cfa-miR-21	↑	hsa-miR-21-5p	↑
cfa-miR-29b	↑	hsa-miR-29b-3p	↑
cfa-miR-125b	↓	hsa-miR-125b-5p	↓
cfa-miR-145	=	hsa-miR-145-5p	↓
cfa-miR-155	↓	hsa-miR-155-5p	↓
cfa-miR-181b	↑	hsa-miR-181b-5p	↑
EMT
cfa-miR-141	↓	hsa-miR-141-3p	↓
cfa-miR-200a	↓	hsa-miR-200a-5p	↓
cfa-miR-200b	↓	hsa-miR-200b-5p	↓
cfa-miR-200c	↓	hsa-miR-200c-5p	↓
cfa-miR-429	↓	hsa-miR-429	↓
B-CLL/T-CLL
cfa-miR-15a	↓/↓	hsa-miR-15a-5p	↓/–
cfa-miR-16	↓/↓	hsa-miR-16-5p	↓/–
cfa-miR-21	↑/↑	hsa-miR-21-5p	↑/–
cfa-miR-29b	↑/↑	hsa-miR-29b	↓/–
cfa-miR-125b	↑/↓	hsa-miR-125b	↑/–
cfa-miR-150	↑/↑	hsa-miR-150-5p	↑/–
cfa-miR-155	↑/↑	hsa-miR-155-5p	↑/–
cfa-miR-181a	↓/↓	hsa-miR-181a-5p	↓/–
MELANOMA
cfa-miR-145	↓	hsa-miR-145-5p	↓
cfa-miR-203	↓	hsa-miR-203a	↓
cfa-miR-205	↓	hsa-miR-205-5p	↓
OSTEOSARCOMA
cfa-miR-134	↓	hsa-miR-134	↓
cfa-miR-544	↓	hsa-miR-544a	↓

In the 1st column are the canine and in the 3rd the human miRNAs listed. In the 2nd and 4th column the relative expression or tendencies in comparison to non-neoplastic samples are presented. “–” indicates that no reports were found for involvement in CLL. “=” means that no differences in expression between tumor and healthy cells were described. “↑” signifies upregulation or “↓” downregulation in comparison to non-neoplastic samples.